FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308134793> ?p ?o ?g. }

• W4308134793 endingPage "A606" @default.
• W4308134793 startingPage "A606" @default.
• W4308134793 abstract "Abstract Backgrounds Craniosynostosis syndrome has a variety of causes, one of which is an autosomal dominant disorder associated with FGFR1 or FGFR2 gene mutation known as Pfeiffer syndrome (PS; OMIM 101600). It is known that PS is clinically diagnosed, not genetic judgment. PS is divided into three subtypes depending on severity of specific phenotypes. Patients with PS type 1 are broad thumbs and great toes, brachydactyly or syndactyly. They have widely spaced eyes, midface hypoplasia and dental abnormalities but short stature is not typical phenotype of PS. We report the patient who were clinically diagnosed PS with short stature because of growth hormone deficiency (GHD). Case Report: A 4 years 7 month-old girl presented with a short stature below the 3rd percentile. She was born at 40 weeks of gestation with a birth weight of 2.9 kg. Her perinatal and neonatal histories were unremarkable. Her parents are non-consanguineous and her mother had micro- pituitary adenoma. She has healthy younger brother who aged 9 months old. In physical examination, height was 91.1 cm (-3.92 SDS), weight was 15.5 kg (-1.15 SDS). Wide thumb and great toes on both sides of her are observed. At the time of admission, bone age was advanced, measured 7 years. There were no specific findings other than a decrease in IGF-1 level (108.24 ng/ml) and increase in prolactin level (27.26 ng/ml) on the basic endocrine examination. The growth hormone (GH) induced stimulation test was performed after admission. She underwent GH induced stimulation test with combinations of 2 stimulants to assess GH secretion: levodopa 150 mg and arginine 0.5 g/kg. The peak GH level was 7.41 ng/ml in levodopa test and 5.58 ng/ml after 30 minutes’ response to arginine. She was diagnosed as a partial GHD defined by peak GH between 5 and 10 ng/ml in both test. There were no findings in karyotyping and chromosomal microarray. As a result of targeted panel sequencing of 233 genes related to hereditary short stature, c.2398dupT, a pathogenic variant that had not been previously reported in the FGFR2 gene, was observed in a heterozygous form as the cause of short stature. Subsequently, recombinant human GH has been administered in units of 0.1 per day according to her weight. The height was increased from 93.6 cm (SDS) in 4 years 10 months old to 98 cm in 5 years 2 months. Any side effects or adverse reactions were not observed during the treatment period. Conclusion It is suggested that a growth hormone test be performed for Pfeiffer syndrome patients with short stature. GH may help growth in patients with positive in the test. Presentation: No date and time listed" @default.
• W4308134793 created "2022-11-08" @default.
• W4308134793 creator A5012777803 @default.
• W4308134793 creator A5025415248 @default.
• W4308134793 date "2022-11-01" @default.
• W4308134793 modified "2023-09-30" @default.
• W4308134793 title "ODP393 Pfeiffer syndrome with growth hormone deficiency in a 4-year-old girl" @default.
• W4308134793 doi "https://doi.org/10.1210/jendso/bvac150.1257" @default.
• W4308134793 hasPublicationYear "2022" @default.
• W4308134793 type Work @default.
• W4308134793 citedByCount "0" @default.
• W4308134793 crossrefType "journal-article" @default.
• W4308134793 hasAuthorship W4308134793A5012777803 @default.
• W4308134793 hasAuthorship W4308134793A5025415248 @default.
• W4308134793 hasBestOaLocation W43081347931 @default.
• W4308134793 hasConcept C126322002 @default.
• W4308134793 hasConcept C134018914 @default.
• W4308134793 hasConcept C141071460 @default.
• W4308134793 hasConcept C187212893 @default.
• W4308134793 hasConcept C2777202849 @default.
• W4308134793 hasConcept C2777871287 @default.
• W4308134793 hasConcept C2779952775 @default.
• W4308134793 hasConcept C2780327212 @default.
• W4308134793 hasConcept C2781133459 @default.
• W4308134793 hasConcept C2910005497 @default.
• W4308134793 hasConcept C2984496839 @default.
• W4308134793 hasConcept C527108885 @default.
• W4308134793 hasConcept C71315377 @default.
• W4308134793 hasConcept C71924100 @default.
• W4308134793 hasConceptScore W4308134793C126322002 @default.
• W4308134793 hasConceptScore W4308134793C134018914 @default.
• W4308134793 hasConceptScore W4308134793C141071460 @default.
• W4308134793 hasConceptScore W4308134793C187212893 @default.
• W4308134793 hasConceptScore W4308134793C2777202849 @default.
• W4308134793 hasConceptScore W4308134793C2777871287 @default.
• W4308134793 hasConceptScore W4308134793C2779952775 @default.
• W4308134793 hasConceptScore W4308134793C2780327212 @default.
• W4308134793 hasConceptScore W4308134793C2781133459 @default.
• W4308134793 hasConceptScore W4308134793C2910005497 @default.
• W4308134793 hasConceptScore W4308134793C2984496839 @default.
• W4308134793 hasConceptScore W4308134793C527108885 @default.
• W4308134793 hasConceptScore W4308134793C71315377 @default.
• W4308134793 hasConceptScore W4308134793C71924100 @default.
• W4308134793 hasIssue "Supplement_1" @default.
• W4308134793 hasLocation W43081347931 @default.
• W4308134793 hasLocation W43081347932 @default.
• W4308134793 hasOpenAccess W4308134793 @default.
• W4308134793 hasPrimaryLocation W43081347931 @default.
• W4308134793 hasRelatedWork W2024433060 @default.
• W4308134793 hasRelatedWork W2086169982 @default.
• W4308134793 hasRelatedWork W2105710561 @default.
• W4308134793 hasRelatedWork W2144496218 @default.
• W4308134793 hasRelatedWork W2369995227 @default.
• W4308134793 hasRelatedWork W2370315044 @default.
• W4308134793 hasRelatedWork W2744321909 @default.
• W4308134793 hasRelatedWork W3047965675 @default.
• W4308134793 hasRelatedWork W4206439172 @default.
• W4308134793 hasRelatedWork W4308134793 @default.
• W4308134793 hasVolume "6" @default.
• W4308134793 isParatext "false" @default.
• W4308134793 isRetracted "false" @default.
• W4308134793 workType "article" @default.